Skip to main content

Advertisement

Log in

Sentinel lymph node in melanoma: present aspects and future trends

  • Review Article
  • Published:
Clinical and Translational Imaging Aims and scope Submit manuscript

Abstract

In melanoma, the sentinel lymph node (SLN) status is the most important factor determining overall survival. Lymphoscintigraphy is a current practice evolving since more than 20 years. It represents the standard practice in detecting SLN and includes dynamic imaging and SPECT/CT. This article reviews the different technical aspects of lymphoscintigraphy with their advantages. It also reviews the main other ways of SLN imaging in melanoma, including more specific techniques, some of them representing a field of research. A PUBMED (MeSH) search was performed with the following keywords: sentinel lymph node melanoma imaging and reviewed relevant articles. We excluded case reports, publications with an Impact Factor lower than 2 and older than 10 years. The use of dynamic and delayed images combined with preoperative SPECT/CT and blue dye during surgery remains the method of choice in sentinel lymph node melanoma detection. SPECT/CT provides several advantages, in particular a higher rate of node detection, better nodes localization and reduction of operative time, with significantly reducing costs. To provide longer retention in lymphatic nodes, some targeted agents are developed but their clinical use is limited. Lymphatic staging with imaging contrast agents could directly assess nodal status without surgery and could be a promising method for the future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Chakera AH, Hesse B, Burak Z, Ballinger JR, Britten A, Caracò C, Cochran AJ, Cook MG, Drzewiecki KT, Essner R, Even-Sapir E, Eggermont AM, Stopar TG, Ingvar C, Mihm MC Jr, McCarthy SW, Mozzillo N, Nieweg OE, Scolyer RA, Starz H, Thompson JF, Trifirò G, Viale G, Vidal-Sicart S, Uren R, Waddington W, Chiti A, Spatz A, Testori A (2009) European Association of Nuclear Medicine-European Organisation for Research and EANM-EORTC general recommendations for sentinel node diagnostics in melanoma. Eur J Nucl Med Mol Imaging 36:1713–1742. doi:10.1007/s00259-009-1228-4

    Article  CAS  PubMed  Google Scholar 

  2. Balch CM, Soong SJ, Gershenwald JE, Thomspon JF, Reintgen DS, Cascinelli N, Urist M, McMasters KM, Ross MI, Kirkwood JM, Atkins MB, Thompson JA, Coit DG, Byrd D, Desmond R, Zhang Y, Liu PY, Lyman GH, Morabito A (2001) Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 19:3622–3634

    CAS  PubMed  Google Scholar 

  3. Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, Puleo CA, Coventry BJ, Kashani-Sabet M, Smithers BM, Paul E, Kraybill WG, McKinnon JG, Wang HJ, Elashoff R, Faries MB, MSLT Group (2014) Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 370:599–609. doi:10.1056/NEJMoa1310460

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, Fleming ID, Gershenwald JE, Houghton A Jr, Kirkwood JM, McMasters KM, Mihm MF, Morton DL, Reintgen DS, Ross MI, Sober A, Thompson JA, Thompson JF (2001) Final version of the Americain Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 19:3635–3648

    CAS  PubMed  Google Scholar 

  5. Lens MB, Dawes M, Newton-Bishop JA, Goodacre T (2002) Tumour thickness as a predictor of occult lymph node metastases in patients with stage I and II melanoma undergoing sentinel lymph node biopsy. Br J Surg 89:1223–1227

    Article  CAS  PubMed  Google Scholar 

  6. Coit DG, Thompson JA, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE 3rd, Daniels GA, Daud A, Dimaio D, Fleming MD, Gonzalez R, Guild V, Halpern AC, Hodi FS Jr, Kelley MC, Khushalani NI, Kudchadkar RR, Lange JR, Martini MC, Olszanski AJ, Ross MI, Salama A, Swetter SM, Tanabe KK, Trisal V, Urist MM, McMillian NR, Ho M (2014) National Comprehensive Cancer Network Melanoma, version 4.2014. J Natl Compr Canc Netw 12:621–629

    CAS  PubMed  Google Scholar 

  7. Lin D, Franc BL, Kashani-Sabet M, Singer MI (2006) Lymphatic drainage patterns of head and neck cutaneous melanoma observed on lymphoscintigraphy and sentinel lymph node biopsy. Head Neck 28:249–255

    Article  PubMed  Google Scholar 

  8. Intenzo CM, Truluck CA, Kushen MC, Kim SM, Berger A, Kairys JC (2009) Lymphoscintigraphy in cutaneous melanoma: an updated total body atlas of sentinel node mapping. Radiographics 29:1125–1135. doi:10.1148/rg.294085745

    Article  PubMed  Google Scholar 

  9. Uren RF, Howman-Giles RB, Shaw HM, Thompson JF, McCarthy WH (1993) Lymphoscintigraphy in high-risk melanoma of the trunk: predicting draining node groups, defining lymphatic channels and locating the sentinel node. J Nucl Med 34:1435–1440

    CAS  PubMed  Google Scholar 

  10. Mahieu-Renard L, Cammilleri S, Giorgi R, Gaudy-Marqueste C, Mundler O, Richard MA, Grob JJ (2008) Slow dynamics of lymphoscintigraphic mapping is associated to the negativity of the sentinel node in melanoma patients. Ann Surg Oncol 15:2878–2886. doi:10.1245/s10434-008-0080-2

    Article  PubMed  Google Scholar 

  11. Nielsen KR, Chakera AH, Hesse B, Scolyer RA, Stretch JF, Thompson JF, Nielsen MB, Uren RF, Oturai PS (2011) The diagnostic value of adding dynamic scintigraphy to standard delayed planar imaging for sentinel node identification in melanoma patients. Eur J Nucl Med Mol Imaging 38:1999–2004. doi:10.1007/s00259-011-1880-3

    Article  PubMed  Google Scholar 

  12. Valdés Olmos RA, Rietbergen DD, Vidal-Sicart S, Manca G, Giammarile F, Mariani G (2014) Contribution of SPECT/CT imaging to radioguided sentinel lymph node biopsy in breast cancer, melanoma, and other solid cancers: from “open and see” to “see and open”. Q J Nucl Med Mol Imaging 58:127–139

    PubMed  Google Scholar 

  13. Uren RF (2009) SPECT/CT Lymphoscintigraphy to locate the sentinel lymph node in patients with melanoma. Ann Surg Oncol 16:1459–1460. doi:10.1245/s10434-009-0463-z

    Article  PubMed  Google Scholar 

  14. Vermeeren L, Valdés Olmos RA, Klop WM, van der Ploeg IM, Nieweg OE, Balm AJ, van den Brekel MW (2011) SPECT/CT for sentinel lymph node mapping in head and neck melanoma. Head Neck 33:1–6. doi:10.1002/hed.21392

    Article  PubMed  Google Scholar 

  15. van der Ploeg IM, Valdés Olmos RA, Kroon BB, Wouters MW, van den Brekel MW, Vogel WV, Hoefnagel CA, Nieweg OE (2009) The yield of SPECT/CT for anatomical lymphatic mapping in patients with melanoma. Ann Surg Oncol 16:1537–1542. doi:10.1245/s10434-009-0339-2

    Article  PubMed  Google Scholar 

  16. Stofeels I, Boy C, Pöppel T, Kuhn J, Klötgen K, Dissemond J, Schadendorf D, Klode J (2012) Association between sentinel lymph node excision with or without preoperative SPECT/CT and metastatic node detection and disease-free survival in melanoma. JAMA 308:1007–1014. doi:10.1001/2012.jama.11030

    Article  Google Scholar 

  17. Ishihara T, Kaguchi A, Matsushita S, Shiraishi S, Tomiguchi S, Yamashita Y, Kageshita T, Ono T (2006) Management of sentinel lymph nodes in malignant skin tumors using dynamic lymphoscintigraphy and the single-photon-emission computed tomography/computed tomography combined system. Int J Clin Oncol Jun 11:214–220

    Article  Google Scholar 

  18. Klode J, Poeppel T, Boy C, Mueller S, Schadendorf D, Körber A, Stoffels I, Dissemond J (2011) Advantages of preoperative hybrid SPECT/CT in detection of sentinel lymph nodes in cutaneous head and neck malignancies. J Eur Acad Dermatol Venereol 25:1213–1221. doi:10.1111/j.1468-3083.2010.03954.x

    Article  CAS  PubMed  Google Scholar 

  19. Stoffels I, Müller M, Geisel MH, Leyh J, Pöppel T, Schadendorf D, Klode J (2014) Cost-effectiveness of preoperative SPECT/CT combined with lymphoscintigraphy vs. lymphoscintigraphy for sentinel lymph node excision in patients with cutaneous malignant melanoma. Eur J Nucl Med Mol Imaging 41:1723–1731. doi:10.1007/s00259-014-2771-1

    Article  PubMed  Google Scholar 

  20. Valsecchi ME, Silbermins D, de Rosa N, Wong SL, Lyman GH (2011) Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma: a meta-analysis. J Clin Oncol 29:1479–1487

    Article  PubMed  Google Scholar 

  21. Morton DL, Cochran AJ, Thompson JF, Elashoff R, Essner R, Glass EC, Mozzillo N, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, Reintgen DS, Coventry BJ, Wang HJ (2005) Multicenter Selective Lymphadenectomy Trial Group. Sentinel node biopsy for early-stage melanoma:accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg 242:302–311 discussion 311-3

    PubMed Central  PubMed  Google Scholar 

  22. Albertini JJ, Cruse CW, Rapaport D, Wells K, Ross M, DeConti R, Berman CG, Jared K, Messina J, Lyman G, Glass F, Fenske N, Reintgen DS (1996) Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 223:217–224

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. Liu Y, Truini C, Ariyan S (2008) A randomized study comparing the effectiveness of methylene blue dye with lymphazurin blue dye in sentinel lymph node biopsy for the treatment of cutaneous melanoma. Ann Surg Oncol 15:2412–2417. doi:10.1245/s10434-008-9953-7

    Article  PubMed  Google Scholar 

  24. Manca G, Romanini A, Pellegrino D, Borsò E, Rondini M, Orlandini C, Zucchi V, Pasqualetti F, Mariani G (2008) Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma. J Nucl Med 49:1769–1775. doi:10.2967/jnumed.108.055350

    Article  PubMed  Google Scholar 

  25. Liu LC, Parrett BM, Jenkins T, Lee W, Morita E, Treseler P, Huange L, Thummala S, Allen RE, Kashani-Sabet M, Leong SP (2011) Selective sentinel lymph node dissection for melanoma: importance of harvesting nodes with lower radioactive counds without the need for blue dye. Ann Surg Oncol 18:2919–2924. doi:10.1245/s10434-011-1689-0

    Article  PubMed  Google Scholar 

  26. Chakera AH, Lock-Andersen J, Hesse U, Nürnberg BM, Juhl BR, Stokholm KH, Drzewiecki T, Hesse B (2009) One-day or two-day procedure for sentinel node biopsy in melanoma? Eur J Nucl Med Mol Imaging 36:928–937. doi:10.1007/s00259-008-1036-2

    Article  CAS  PubMed  Google Scholar 

  27. Stoffels I, Poeppel T, Boy C, Mueller S, Wichmann F, Dissemond J, Schadendorf D, Rosenbaum-Krumme S, Klode J (2012) Radio-guided surgery: advantages of a new portable γ-camera (Sentinella) for intraoperative real time imaging and detection of sentinel lymph nodes in cutaneous malignancies. J Eur Acad Dermatol Venereol 26:308–313. doi:10.1111/j.1468-3083.2011.04057.x

    Article  CAS  PubMed  Google Scholar 

  28. Vermeeren L, Valdés Olmos RA, Klop WM, Balm AJ, van den Brekel MW (2010) A portable gamma-camera for intraoperative detection of sentinel nodes in the head and neck region. J Nucl Med 51:700–703. doi:10.2967/jnumed.109.071407

    Article  PubMed  Google Scholar 

  29. Dengel LT, More MJ, Judy PG, Petroni GR, Me Smolkin, Rehm PK, Majewski S, Williams MB, Slingluff CL Jr (2011) Intraoperative imaging guidance for sentinel node biopsy in melanoma using a mobile gamma camera. Ann Surg 253:774–778. doi:10.1097/SLA.0b013e3181f9b709

    Article  PubMed  Google Scholar 

  30. Mihaljevic AL, Rieger A, Belloni B, Hein R, Okur A, Scheidhauer K, Schuster T, Friess H, Martignoni ME (2014) Transferring innovative freehand SPECT to the operating room: first experiences with sentinel lymph node biopsy in malignant melanoma. Eur J Surg Oncol 40:42–48. doi:10.1016/j.ejso.2013.09.005

    Article  CAS  PubMed  Google Scholar 

  31. Manca G, Rubello D, Romanini A, Boni G, Chiacchio S, Tredici M, Mazzarri S, Duce V, Colletti PM, Volterrani D, Mariani G (2014) Sentinel lymph node mapping in melanoma: the issue of false-negative findings. Clin Nucl Med 39:e346–e354. doi:10.1097/RLU.0000000000000366

    Article  PubMed  Google Scholar 

  32. Lam TK, Uren RF, Scolyer RA, Quinn MJ, Shannon KF, Thompson JF (2009) False-negative sentinel node biopsy because of obstruction of lymphatics by metastatic melanoma: the value of ultrasound in conjunction with preoperative lymphoscintigraphy. Melanoma Res 19:94–99. doi:10.1097/CMR.0b013e32832166b7

    Article  PubMed  Google Scholar 

  33. Voit CA, van Akkooi AJ, Schäfer-Hesterberg G, Sterry W, Eggermont AM (2010) The value of preoperative ultrasound (after lymphoscintigraphy) in conjunction with pre-sentinel lymph node biopsy fine-needle aspiration outweighs the usage of ultrasound alone in conjunction with lymphoscintigraphy: the need for an algorithm. Melanoma Res 20:357–359. doi:10.1097/CMR.0b013e32833adf13

    Article  PubMed  Google Scholar 

  34. Solari N, Gipponi M, Stella M, Queirolo P, di Somma C, Villa G, Piccardo A, Gualco M, Cardinale F, Cafiero F (2009) Predictive role of preoperative lymphoscintigraphy on the status of the sentinel lymph node in clinically node-negative patients with cutaneous melanoma. Melanoma 19:243–251. doi:10.1097/CMR.0b013e32832e0b9a

    Article  Google Scholar 

  35. Trifiro G, Verrecchia F, Soteldo J, Zonta M, Pizzigoni S, Travaini LL, Baldini F, Tosti G, Mosconi M, Paganelli G, Mazzarol G, Testori A (2008) Modification of lymphoscintigraphic sentinel node identification before and after excisional biopsy of primary cutaneous melanoma. Melanoma Res 18:373–377. doi:10.1097/CMR.0b013e328307c231

    Article  PubMed  Google Scholar 

  36. Nejc D, Wrzesień M, Piekarski J, Olszewski J, Pluta P, Kuśmierek J, Jeziorski A (2006) Sentinel node biopsy in skin melanoma patients—measurements of absorbed doses of radiation to the hands of medical staff. J Surg Oncol 93:355–361

    Article  PubMed  Google Scholar 

  37. Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, Reintgen DS, Coventry BJ, Glass EC, Wang HJ, MSLT Group (2006) Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 355:1307–1317

    Article  CAS  PubMed  Google Scholar 

  38. Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, Puleo CA, Coventry BJ, Kashani-Sabet M, Smithers BM, Paul E, Kraybill WG, McKinnon JG, Wang HJ, Elashoff R, Faries MB, MSLT Group (2014) Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med 370:599–609

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  39. Vera DR, Wisner ER, Stadalnik RC (1997) Sentinel node imaging via a nonparticulate receptor-binding radiotracer. J Nucl Med 38:530–535

    CAS  PubMed  Google Scholar 

  40. Wallace AM, Hoh CK, Ellner SJ, Darrah DD, Schulteis G, Vera DR (2007) Lymphoseek: a molecular imaging agent for melanoma sentinel lymph node mapping. Ann Surg Oncol 14:913–921

    Article  PubMed  Google Scholar 

  41. Wallace AM, Hoh CK, Limmer KK, Darrah DD, Schulteis G, Vera DR (2009) Sentinel lymph node accumulation of Lymphoseek and Tc-99 m-sulfur colloid using a “2-day” protocol. Nucl Med Biol 36:687–692. doi:10.1016/j.nucmedbio.2009.04.007

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  42. Sondak VK, King DW, Zager JS, Schneebaum S, Kim J, Leong SP, Faries MB, Averbook BJ, Martinez SR, Puleo CA, Messina JL, Christman L, Wallace AM (2013) Combined analysis of phase III trials evaluating [(9)(9)mTc]tilmanocept and vital blue dye for identification of sentinel lymph nodes in clinically node-negative cutaneous melanoma. Ann Surg Oncol 20:680–688. doi:10.1245/s10434-012-2612-z

    Article  PubMed Central  PubMed  Google Scholar 

  43. Tanaka E, Choi HS, Fujii H, Bawendi MG, Frangioni JV (2006) Image-guided oncologic surgery using invisible light: completed pre-clinical development for sentinel lymph node mapping. Ann Surg Oncol 13:1671–1681

    Article  PubMed Central  PubMed  Google Scholar 

  44. Mieog JS, Troyan SL, Hutteman M, Donohoe KJ, van der Vorst JR, Stockdale A, Liefers GJ, Choi HS, Gibbs-Strauss SL, Putter H, Gioux S, Kuppen PJ, Ashitate Y, Löwik CW, Smit VT, Oketokoun R, Ngo LH, van de Velde CJ, Frangioni JV, Vahrmeijer AL (2011) Toward optimization of imaging system and lymphatic tracer for near-infrared fluorescent sentinel lymph node mapping in breast cancer. Ann Surg Oncol 18:2483–2491. doi:10.1245/s10434-011-1566-x

    Article  PubMed Central  PubMed  Google Scholar 

  45. Hutteman M, Mieog JS, van der Vorst JR, Liefers GJ, Putter H, Löwik CW, Frangioni JV, van de Velde CJ, Vahrmeijer AL (2011) Randomized, double-blind comparison of indocyanine green with or without albumin premixing for near-infrared fluorescence imaging of sentinel lymph nodes in breast cancer patients. Breast Cancer Res Treat 127:163–170. doi:10.1007/s10549-011-1419-0

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  46. Bredell MG (2010) Sentinel lymph node mapping by indocyanin green fluorescence imaging in oropharyngeal cancer: preliminary experience. Head Neck Oncol 2:31. doi:10.1186/1758-3284-2-31

    Article  PubMed Central  PubMed  Google Scholar 

  47. Brouwer OR, Klop WM, Buckle T, Vermeeren L, van den Brekel MW, Balm AJ, Nieweg OE, Valdés Olmos RA, van Leeuwen FW (2012) Feasibility of sentinel node biopsy in head and neck melanoma using a hybrid radioactive and fluorescent tracer. Ann Surg Oncol 19:1988–1994. doi:10.1245/s10434-011-2180-7

    Article  PubMed Central  PubMed  Google Scholar 

  48. Hayashi T, Furukawa H, Oyama A, Funayama E, Saito A, Yamao T, Yamamoto Y (2012) Sentinel lymph node biopsy using real-time fluorescence navigation with indocyanine green in cutaneous head and neck/lip mucosa melanomas. Head Neck 34:758–761. doi:10.1002/hed.21651

    Article  PubMed  Google Scholar 

  49. Brouwer OR, Buckle T, Vermeeren L, Klop WM, Balm AJ, van der Poel HG, van Rhijn BW, Horenblas S, Nieweg OE, van Leeuwen FW, Valdés Olmos RA (2012) Comparing the hybrid fluorescent-radioactive tracer indocyanine green-99 mTc-nanocolloid with 99 mTc-nanocolloid for sentinel node identification: a validation study using lymphoscintigraphy and SPECT/CT. J Nucl Med 53:1034–1040. doi:10.2967/jnumed.112.103127

    Article  CAS  PubMed  Google Scholar 

  50. Fujisawa Y, Nakamura Y, Kawachi Y, Otsuka F (2012) Indocyanine green fluorescence-navigated sentinel node biopsy showed higher sensitivity that the radioisotope or blue dye method, which may help to reduce false-negative cases in skin cancer. J Surg Oncol 106:41–45. doi:10.1002/jso.23045

    Article  PubMed  Google Scholar 

  51. Gilmore DM, Khullar OV, Gioux S, Stockdale A, Frangioni JV, Colson YL, Russell SE (2013) Effective low-dose escalation of indocyanine green for near-infrared fluorescent sentinel lymph node mapping in melanoma. Ann Surg Oncol 20:2357–2363. doi:10.1245/s10434-013-2905-x

    Article  PubMed  Google Scholar 

  52. Notohamiprodjo M, Weiss M, Baumeister RG, Sommer WH, Helck A, Crispin A, Reiser MF, Herrmann KA (2012) MR lymphangiography at 3.0 T: correlation with lymphoscintigraphy. Radiology 264:78–87. doi:10.1148/radiol.12110229

    Article  PubMed  Google Scholar 

  53. Madru R, Kjellman P, Olsson F, Wingardh K, Ingvar C, Stahlberg F, Olsrud J, Lätt J, Fredriksson S, Knutsson L, Strand SE (2012) 99mTc-labeled superparamagnetic iron oxide nanoparticles for multimodality SPECT/MRI of sentinel lymph nodes. J Nucl Med 53:459–463. doi:10.2967/jnumed.111.092437

    Article  CAS  PubMed  Google Scholar 

  54. Harisinghani MG, Saksena MA, Hahn PF, King B, Kim J, Torabi MT, Weissleder R (2006) Ferumoxtran-10-enhanced MR lymphangiography: does contrast-enhanced imaging alone suffice for accurate lymph node characterization? Am J Roentgenol 186:144–148

    Article  Google Scholar 

  55. Shimuzu S, Hosokawa M, Itoh K, Fujita M, Takahashi H, Shirato H (2009) Can hybrid FDG-PET/CT detect subclinical lymph node metastasis of oesophageal cancer appropriately and contribute to radiation treatment planning? A comparison of image-based and pathological findings. Int J Clin Oncol 14:421–425. doi:10.1007/s10147-009-0893-4

    Article  Google Scholar 

  56. Crippa F, Leutner M, Belli F, Gallino F, Greco M, Pilotti S, Cascinelli N, Bombardieri E (2000) Which kinds of lymph node metastases can FDG PET detect? A clinical study in melanoma. J Nucl Med 41:1491–1494

    CAS  PubMed  Google Scholar 

  57. Singh B, Ezziddin S, Palmedo H, Reinhardt M, Strunk H, Tüting T, Biersack HJ, Ahmadzadehfar H (2008) Preoperative 18F-FDG-PET/CT imaging and sentinel node biopsy in the detection of regional lymph node metastases in malignant melanoma. Melanoma Res 18:346–352. doi:10.1097/CMR.0b013e32830b363b

    Article  PubMed  Google Scholar 

  58. Cousins A, Thompson SK, Wedding AB, Thierry B (2014) Clinical relevance of novel imaging technologies for sentinel lymph node identification and staging. Biotechnol Adv 32:269–279. doi:10.1016/j.biotechadv.2013.10.011

    Article  PubMed  Google Scholar 

  59. Brader P, Kelly K, Gang S, Shah JP, Wong RJ, Hricak H, Blasberg RG, Fond Y, Gil Z (2009) Imaging of lymph node micrometastases using an oncolytic herpes virus and [F]FEAU PET. PLoS ONE 4:e4789. doi:10.1371/journal.pone.0004789

    Article  PubMed Central  PubMed  Google Scholar 

  60. Tafreshi NK, Bui MM, Bishop K, Lloyd MC, Enkemann SA, Lopez AS, Abrahams D, Carter BW, Vagner J, Grobmyer SR, Gobmyer SR, Gillies RJ, Morse DL (2012) Noninvasive detection of breast cancer lymph node metastasis using carbonic anhydrases IX and XII targeted imaging probes. Clin Cancer Res 18:207–219. doi:10.1158/1078-0432.CCR-11-0238

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  61. Tafreshi NK, Enkemann SA, Bui MM, Lloyd MC, Abrahams D, Huynh AS, Kim J, Grobmyer SR, Carter WB, Vagner J, Gillies RJ, Morse DL (2010) A mammoglobin-A targeting agent for non invasive detection of breast cancer metastasis in lymph nodes. Cancer Res 71:1050–1059. doi:10.1158/0008-5472.CAN-10-3091

    Article  PubMed Central  PubMed  Google Scholar 

  62. Grootendorst DJ, Jose J, Wouters MW, van Boven H, Van der Hage J, Van Leeuwen TG, Steenbergen W, Manohar S, Ruers TJ (2012) First experiences of photoacoustic imaging for detection of melanoma metastases in resected human lymph nodes. Lasers Surg Med 44:541–549. doi:10.1002/ism.22058

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

For this type of study formal consent is not required.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Francesco Giammarile.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bozzetto, J., Dubreuil, J., Rubello, D. et al. Sentinel lymph node in melanoma: present aspects and future trends. Clin Transl Imaging 3, 187–194 (2015). https://doi.org/10.1007/s40336-015-0122-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40336-015-0122-2

Keywords